Exchange: NASDAQ·Updated 07:48 PM EDT
VYGR logo

VYGRVoyager Therapeutics Inc

$3.14
$0.09
(2.95%)
Today
Closed $3.14
$0.01
(0.32%)
After Hours
EarningsAug 5
Mkt Cap$184.28M
Vol687,446.00
News
all
press releases
Voyager Therapeutics (VYGR) is Amongst the Best Stocks Under $10, With More Than 50% Upside
Voyager Therapeutics (VYGR) is Amongst the Best Stocks Under $10, With More Than 50% Upside...
Yahoo! Finance: News
More News
What Voyager Therapeutics Inc (VYGR) Has Gained on Its Therapy Programs
What Voyager Therapeutics Inc (VYGR) Has Gained on Its Therapy Programs...
Yahoo! Finance: News
A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a Premier Longevity Forum: Inside Ava Bio's Cell-Based Platform Approach
A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a Premier Longevity Forum: Inside Ava Bio's Cell-Based Platform Approach A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a...
PR Newswire
Voyager Therapeutics (VYGR) Reports Q1 Loss, Misses Revenue Estimates
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of +12.96% and -74.02%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Voyager Therapeutics (VYGR) to Release Quarterly Earnings on Monday
Voyager Therapeutics (NASDAQ:VYGR) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-voyager-therapeutics-inc-stock...
MarketBeat
Voyager Therapeutics (NASDAQ:VYGR) Share Price Crosses Above Fifty Day Moving Average - Here's Why
Voyager Therapeutics (NASDAQ:VYGR) Shares Cross Above 50-Day Moving Average - Here's What Happened...
MarketBeat
Alfred Sandrock Sells 11,511 Shares of Voyager Therapeutics (NASDAQ:VYGR) Stock
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) CEO Alfred Sandrock sold 11,511 shares of the firm's stock in a transaction on Thursday, April 2nd. The stock was sold at an average price...
MarketBeat
Voyager Therapeutics (NASDAQ:VYGR) CEO Sells $44,547.57 in Stock
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) CEO Alfred Sandrock sold 11,511 shares of Voyager Therapeutics stock in a transaction dated Thursday, April 2nd. The shares were sold at an...
MarketBeat
Voyager Therapeutics (NASDAQ:VYGR) Shares Pass Below 50-Day Moving Average - Should You Sell?
Voyager Therapeutics (NASDAQ:VYGR) Shares Pass Below Fifty Day Moving Average - Here's Why...
MarketBeat
Voyager Therapeutics Conference: CEO Calls 2026 "Year of Tau," Eyes BBB Capsid Clinic Debut
Voyager Therapeutics (NASDAQ:VYGR) CEO Al Sandrock outlined several 2026 priorities in a discussion focused on the company's tau-directed pipeline and its newer blood-brain barrier (BBB)-penetrant capsid platform. Sandrock described 2026 as "the year of tau," while also pointing to upcoming clinical...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.